Use of QTc-prolonging medications among patients with lung cancer: implications for clinical trials and standard clinical care.

e20529Background: Exclusion from cancer clinical trials is common for patients taking QTc-interval prolonging drugs. To estimate the potential impact on accrual, we determined the prevalence of QTc...